AI Tool May Help Predict Risk for Pancreatic Ductal Adenocarcinoma
MONDAY, May 2, 2022 (HealthDay News) -- An artificial intelligence tool can analyze computed tomography (CT) scans of the abdomen to predict risk for developing pancreatic ductal adenocarcinoma (PDAC), according to a study published online April 28 in Cancer Biomarkers.
Touseef Ahmad Qureshi, Ph.D., from Cedars-Sinai Medical Center in Los Angeles, and colleagues developed a tool to stratify individuals at high risk for PDAC by identifying predictive features in prediagnostic abdominal CT scans. A set of CT features was identified in an analysis of 4,000 raw radiomic parameters extracted from prediagnostic scans of pancreases. A naive Bayes classifier was developed for automatic classification of the scans at high PDAC risk. The study included 108 retrospective CT scans (36 each from healthy control, prediagnostic, and diagnostic groups). The model was developed on 66 multiphase scans, and external validation was performed on 42 venous-phase scans.
The researchers found that on the external dataset, the system achieved an average classification accuracy of 86 percent.
"Our hope is this tool could catch the cancer early enough to make it possible for more people to have their tumor completely removed through surgery," Qureshi said in a statement.
Related Posts
Una rutina previa al partido puede mejorar el rendimiento de un deportista, según un estudio
DOMINGO, 28 de noviembre de 2021 (HealthDay News) -- Uno de los grandes de la...
Heart Attack Deaths Fell for Americans Over Past 20 Years
THURSDAY, Feb. 23, 2023 (HealthDay News) -- The United States saw a significant...
El aceite de pescado no tiene ningún efecto en la depresión, encuentra un estudio
MIÉRCOLES, 22 de diciembre de 2021 (HealthDay News) -- Quizá tengan otros...
What Is Metastatic Breast Cancer & How Is It Treated?
MONDAY, June 26, 2023 (HealthDay News) -- Metastatic breast cancer can be a...